MKMaria A. Karpilova

Maria A. Karpilova

*This is an algorithmically generated author record based on publicly available information.

Maria A. Karpilova has a total of 42 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Diagnostic significance of perimetry and microperimetry in common retinal diseases

    by H.S. Ismailova, V.M. Sheludchenko, A.S. Levkina, S. Yusef, M.A. Karpilova

    Perimetry with assessment of the light sensitivity threshold and indices of its loss has wide use in ophthalmology. This review considers three diseases in which static perimetry and microperimetry are used and for which outcome data are available — age-related macular degeneration, diabetic retinopathy, and hypertensive retinopathy. Despite differing opinions on the feasibility of using perimetry in the early stages of these diseases, the obtained data differ from normal values. Microperimetry is more often performed in combination with optical coherence tomography of the retina. Since perimetry is a subjective assessment method, its findings should be verified with the data of local bioelectrical potential, or “objective perimetry”.

  • Open Access

    Ocular fluid dynamics after phakic intraocular lens implantation (a prospective cohort study)

    by Vyacheslav M. Sheludchenko, Nadezhda V. Makashova, Tatiana A. Shchegoleva, Diana V. Andzhelova, Maria A. Karpilova, Щеголева Татьяна Андреевна

    BACKGROUND: A phakic intraocular lens (IOL) in the posterior chamber is weighty, changes topography of structures, and can affect ocular fluid dynamics. AIM: The study aimed to assess the parameters of ocular fluid dynamics after ICL STAAR intraocular lens implantation and their relationship with topography of the phakic intraocular lens position based on ultrasound data. METHODS: From the general population of 98 patients implanted with ICL STAAR V4 phakic intraocular lens as indicated, 10 patients (18 eyes) with myopia of 5–10 D were randomly selected with their consent to study ocular fluid dynamics. Intraocular pressure was measured using an ocular response analyzer, and corneal-compensated and Goldman intraocular pressure was recorded. Tonography was performed using GlauTest-60. Outflow facility (C) and Becker ratio were calculated. Ultrasound was performed using Aviso Quantel Medical with a 50 MHz high-resolution (linear technology) and Clear Scan scleral probe. Visits were planned before surgery and 3 months post-operatively. RESULTS: Corneal-compensated intraocular pressure was 14.86 ± 2.63 preoperatively and 13.12 ± 3.64 mmHg 3 moths postoperatively; Goldman intraocular pressure changed from 13.12 ± 3.64 to 13.38 ± 3.90. Pre- and postoperative true intraocular pressure (P0) was 13.3 ± 5.60 and 11.75 ± 1.99 mmHg, respectively. Pre- and postoperative outflow facility was 0.23 ± 0.08 and 0.22 ± 0.07 mm3/min•mmHg, respectively. Pre- and postoperative Becker ratio was 52.64 ± 31.59 and 58.81 ± 21.87, respectively. All parameters did not differ significantly after surgery. CONCLUSION: Ocular fluid dynamics do not change considerably after implantation of posterior chamber phakic intraocular lenses (ICL STAAR V4c). This can be explained by the optimal design parameters and lens shape, which create a synergistic effect of its elements with multidirectional tension from the fixation point in the iris to the fulcrum in the ciliary body.

  • Rationale for the application of modern magnetotherapy technologies for dry eye syndrome, glaucoma and cataract

    by A. G. Egiаzarova, A. K. Raifeld, N. B. Korchazhkina, V. E. Illarionov, A. A. Mikhailova, M. A. Elfimov, V. V. Yamenskov, V. A. Pavlov, Moscow Fsbi Main Military Clinical Hospital Named After Аcademician N. N. Burdenko Of The Ministry Of Defense Of The Russian Federation, V. M. Sheludchenko, et al.

    Purpose of the study. The article outlines the basic terms and concepts of information interactions of structures and systems of living organisms, provides a modern approach to the problems of optimizing medical rehabilitation through various methods of magnetic therapy, taking into account the biological effect and characteristics of the impact of various types of magnetic fields, and presents the pathogenetic conditionality of the use of magnetic techniques by means of the Ophthalmag device for the treatment of dry eye syndrome, glaucoma, and cataract.

  • Influence of corneal curvature and peripheral thickness on tonometry readings

    by A.A. Antonov, A.V. Volzhanin, E.A. Klinicheva, M.A. Karpilova

    PURPOSE This study investigates the influence of peripheral corneal thickness (PCT) and its curvature on tonometry readings. MATERIAL AND METHODS The study included 49 patients (49 eyes) who were indicated for glaucoma surgery. Using bidirectional applanation tonometry, the following parameters were obtained: IOPcc, IOPg — intraocular pressure (IOP) corrected for corneal compensation, taken as the most reliable indicator; IOP converted to Goldmann measurement, taken as the result of applanation tonometry, ΔIOP (IOPcc—IOPg), CH and CRF (corneal hysteresis and corneal resistance factor). During corneal topography, the corneal thickness was studied in the center, PCT at 1.5; 2, 3, 4 and 5 mm from the center in four meridians, as well as ΔPCT (PCT 3 mm — PCT 1.5 mm), the curvature of the anterior and posterior surfaces of the cornea and the depth of the anterior chamber. Aberrometry was used to obtain refractometry data and the curvature of the anterior surface of the cornea. The influence of the studied parameters on ΔIOP was evaluated. RESULTS ΔIOP correlated with CRF (r= –0.652), CH (r= –0.873), central corneal thickness (r= –0.293), PCT at all distances except 5 mm (r= –0.297; –0.287; –0.302; –0.303), with the strong and weak meridians of the anterior surface of the cornea (r=0.328; r=0.315), with the strong and weak meridians of the posterior surface, as well as the average curvature of the posterior surface (r=0.307; r=0.332; r=0.328). After step-by-step selection of the above parameters for creating a linear regression model for ΔIOP calculation, CH, CRF and PCT1.5mm remained in the model. The model describes ΔIOP with high accuracy (R2=0.974). CONCLUSION Biomechanical parameters of the cornea are the leading factor of applanation tonometry error. Individual linear dimensions of the cornea (thickness, curvature) have a lesser effect.

  • Physiotherapeutic methods in ophthalmic rehabilitation of patients with glaucoma and cataract

    by V.V. Yamenskov, V.A. Pavlov, A.K. Drakon, V.M. Sheludchenko, M.A. Karpilova, M.A. Elfimov, E.S. Vasilieva

    В статье представлен анализ научных публикаций, посвященных применению физиотерапевтических факторов в лечении сочетанной глаукомы и катаракты как одной из основных причин слепоты и слабовидения.


  • Open Access

    The Place of Transscleral Technologies in Laser Treatment of Glaucoma: History, Stages of Development, Prospects

    by Yusef Naim Yusef, A. A. Gamidov, M. A. Karpilova, P. D. Gavrilina, Юсеф Наим Юсеф

    The presence of a balance between the production and outflow of intraocular fluid ensures stability of the level of intraocular pressure (IOP). To reduce IOP means to affect one of these variables. For many decades, transscleral technologies in the treatment of glaucoma were considered exclusively as traumatic cyclodestructive interventions that only affect the reduction of intraocular pressure (IOP). These methods have recently been considered as possible ways to influence uveoscleral outflow. This became possible due to the appearance of new lasers, the development of new modes of their operation, points of application in the projection of the pars plana of the ciliary body (for example, TRANS-scleral CFC in micro-pulse mode at λ = 810 µm and CFC using pulsed periodic laser radiation at λ = 1.56 µm). They have a gentler effect and, accordingly, cause fewer side effects and undesirable effects. This explains the increasing shift towards the use of transscleral technologies in the earlier stages of glaucoma, not only for end-stage painful glaucoma resistant to conventional treatment (so-called “last resort surgery”).


  • Hyperspectral Holography of the Demodex Mite in the Near Infrared Range

    by S. G. Kalenkov, G. S. Kalenkov, M. A. Karpilova, A. E. Shtanko

  • Electrophysiological study of the visual pathway in anti-VEGF therapy of neovascular age-related macular degeneration combined with glaucoma

    by T. V. Smirnova, A. S. Rud'Ko, I. V. Andreeva, M. A. Karpilova

    To assess the effect of intravitreal administration of anti-VEGF drugs ranibizumab and aflibercept on the functional state of the visual pathway in patients with neovascular age-related macular degeneration (nAMD) and primary open-angle glaucoma (POAG) using the method of recording visual evoked potentials (VEP). A total of 54 patients (54 eyes) with nAMD and POAG were examined. The control group consisted of 39 healthy patients (39 eyes). The study included 24 patients (24 eyes) with stage IA POAG, 23 patients (23 eyes) with stage IIA POAG, 7 patients (7 eyes) with stage IIIA POAG. All patients with nAMD and POAG were given intravitreal injection of anti-VEGF drug: 35 patients received ranibizumab, 19 patients received aflibercept. Injections were performed monthly for 3 months. Ophthalmologic examination included visometry, biomicroscopy, retinal OCT using SPECTRALIS tomograph ('Heidelberg Engineering GmbH', Germany). VEP were recorded on EP-1000 Multifocal ('Tomey', Germany). All ophthalmologic studies were performed prior to administration of the anti-VEGF preparation and after the 3rd injection. After the third intravitreal injection of anti-VEGF drugs, best corrected visual acuity (BCVA) increased to 0.46±0.1 (p=0.001). According to OCT, central retinal thickness decreased by an average of 110.6 µm, the total volume of the retina decreased by 1.3 mm3, total thickness RNFL - by 3.8 µm (p0.05). Intravitreal administration of anti-VEGF drugs ranibizumab and aflibercept has no negative influence on the functional state of the visual pathway in patients with nAMD and POAG. Intravitreal injections of ranibizumab and aflibercept can be considered a safe treatment option for patients with nAMD and POAG.

  • [Anti-VEGF drugs in the treatment of neovascular glaucoma].

    by M. A. Karpilova, M. H. Durzhinskaya

    Neovascular glaucoma (NVG) is the most frequently occurring type of secondary glaucoma characterized by significant decrease in visual functions. Its pathogenesis consists mainly of ischemia of the posterior segment, which is often secondary to proliferative diabetic retinopathy or ischemic central retinal vein occlusion. Development of neovascularization in the eye is associated with processes that change homeostatic balance between proangiogenic (vascular endothelial growth factor (VEGF)) and antiangiogenic (pigment epithelium-derived factor (PEDF)) factors. The aim of the therapy is to reduce the production of aqueous humour. Application of antiangiogenic preparations in patients with NVG as adjuvant therapy is the method of choice for both prevention and treatment of the disease. The article reviews literature on current possibilities of using anti-VEGF drugs in the treatment of NVG.


  • [Effect of intravitreal injections of ranibizumab and aflibercept on the retinal nerve fiber layer in patients with concomitant neovascular age-related macular degeneration and glaucoma].

    by A. S. Rud'Ko, M. V. Budzinskaya, I. V. Andreeva, M. A. Karpilova, T. V. Smirnova

    To study the effect of ranibizumab and aflibercept on the thickness of retinal nerve fiber layer (RNFL) in patients with neovascular age-related macular degeneration (nAMD) and primary open-angle glaucoma (POAG). The study included 62 patients (62 eyes) with nAMD and comorbid POAG. Patients were divided into two groups depending on the anti-VEGF treatment. The first group included 42 patients (42 eyes) who received injections of ranibizumab. The second group consisted of 20 patients (20 eyes) who received aflibercept. All patients received three injections of ranibizumab or aflibercept with one-month intervals. In addition to standard ophthalmic examination, patients underwent optical coherence tomography of the macular area and peripapillary RNFL. After anti-VEGF treatment, patients of both groups exhibited improvements expressed in reduced macular edema, increased visual acuity and absence of intraocular pressure (IOP) changes, as well as no statistically significant changes in the width and depth of excavation. There was a statistically significant decrease of peripapillary RNFL thickness in the temporal quadrant after treatment. The decrease of peripapillary RNFL thickness in the temporal quadrant occurs due to resorption of macular edema. In the absence of statistically significant changes in IOP, width and depth of excavation, intravitreal injections of ranibizumab and aflibercept can be considered safe treatment options for patients with concomitant nAMD and POAG.